Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease

• Andrew S. Day,
• Andrew S. Day,
• Mustafa Adamji

Affiliations

Andrew S. Day

Department of Paediatrics, Christchurch Hospital, Christchurch, New Zealand

Andrew S. Day

Department of Paediatrics, University of Otago, Christchurch, New Zealand

Mustafa Adamji

Department of Paediatrics, Christchurch Hospital, Christchurch, New Zealand